COSCIENS Biopharma, Inc. (CSCI.TO)
7.50
+0.26
(+3.59%)
CAD |
TSX |
Aug 25, 16:00
COSCIENS Biopharma Total Assets (Quarterly) : 26.74M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.74M |
| March 31, 2026 | 26.29M |
| December 31, 2025 | 29.38M |
| September 30, 2025 | 33.20M |
| June 30, 2025 | 37.60M |
| March 31, 2025 | 44.82M |
| December 31, 2024 | 50.44M |
| September 30, 2024 | 59.13M |
| June 30, 2024 | 68.48M |
| March 31, 2024 | 43.02M |
| December 31, 2023 | 31.31M |
| September 30, 2023 | 57.44M |
| June 30, 2023 | 61.51M |
| March 31, 2023 | 69.40M |
| December 31, 2022 | 75.91M |
| September 30, 2022 | 91.52M |
| June 30, 2022 | 92.65M |
| March 31, 2022 | 95.36M |
| December 31, 2021 | 101.18M |
| September 30, 2021 | 103.93M |
| June 30, 2021 | 104.45M |
| March 31, 2021 | 109.36M |
| December 31, 2020 | 47.14M |
| September 30, 2020 | 43.11M |
| June 30, 2020 | 24.07M |
| Date | Value |
|---|---|
| March 31, 2020 | 27.96M |
| December 31, 2019 | 25.91M |
| September 30, 2019 | 28.47M |
| June 30, 2019 | 27.12M |
| March 31, 2019 | 29.90M |
| December 31, 2018 | 40.18M |
| September 30, 2018 | 36.79M |
| June 30, 2018 | 41.61M |
| March 31, 2018 | 46.98M |
| December 31, 2017 | 34.71M |
| September 30, 2017 | 28.19M |
| June 30, 2017 | 31.83M |
| March 31, 2017 | 37.45M |
| December 31, 2016 | 42.46M |
| September 30, 2016 | 41.71M |
| June 30, 2016 | 48.14M |
| March 31, 2016 | 56.97M |
| December 31, 2015 | 71.54M |
| September 30, 2015 | 65.56M |
| June 30, 2015 | 71.47M |
| March 31, 2015 | 82.67M |
| December 31, 2014 | 54.94M |
| September 30, 2014 | 62.04M |
| June 30, 2014 | 57.67M |
| March 31, 2014 | 68.04M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Spectral Medical, Inc. | 3.19M |
| Resverlogix Corp. | 11.71M |
| Theratechnologies, Inc. | 70.49M |
| Restart Life Sciences Corp. | 2.284M |
| Defence Therapeutics Inc | 9.446M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.688M |
| Shareholders Equity (Quarterly) | 21.06M |
| Debt to Equity Ratio | 0.1318 |
| Current Ratio | 4.328 |
| Net Debt Paydown Yield | 0.83% |